<DOC>
	<DOCNO>NCT00249171</DOCNO>
	<brief_summary>The purpose study show risperidone ( antipsychotic medication ) combine lorazepam ( anti-anxiety medication ) effective conventional therapy administer intramuscular injection emergency treatment patient schizophrenia .</brief_summary>
	<brief_title>A Study Risperidone Combination With Lorazepam Compared With Standard Therapy Emergency Treatment Schizophrenic Patients</brief_title>
	<detailed_description>Patients acute schizophrenia often anxious uncertain psychotic symptom experience . These patient need rapid help symptom relief . Risperidone , widely use antipsychotic medication , effective positive negative symptom schizophrenia , rapid onset action , low incidence extrapyramidal symptom , , general , mild adverse event . This open-label trial 2 mg dose oral formulation risperidone combination 2 2.5 mg oral lorazepam compare standard care , consist conventional neuroleptic drug administer via intramuscular injection , without lorazepam . Patients require emergency care offer choice two therapy monitor 24 hour initial treatment . Optional follow may perform 2 , 3 , 7 day . The primary measure effectiveness success treatment 2 hour drug administer , indicated patient asleep showing improvement Clinical Global Impression ( CGI ) Improvement subscale . Additional effectiveness assessment include evaluation hostility agitation , assessed Brief Psychiatric Rating Scale ( BPRS ) , degree sedation , ability patient interact physician 1 , 2 , 24 hour start treatment . Safety assessment include incidence adverse event throughout treatment follow period . The study hypothesis oral risperidone combine lorazepam effective therapy conventional neuroleptic intramuscular agent , without lorazepam , emergency treatment patient schizophrenia . Single , oral 2 mg dose risperidone single , oral 2 2.5 mg dose lorazepam ; dose 24 hour period investigator 's discretion . Comparator drug choice ( without lorazepam ) administer intramuscularly accord product labeling .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Psychotic patient schizophrenia require rapid intervention experience symptom psychotic disorder capable choosing treat Patients know hypersensitivity study drug participate investigational drug trial within 30 day study initiation know unresponsive treatment risperidone comparator drug know benzodiazepine dependence ( addiction class antianxiety drug )</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>acute schizophrenia</keyword>
	<keyword>psychosis</keyword>
	<keyword>risperidone</keyword>
	<keyword>lorazepam , antipsychotic agent</keyword>
	<keyword>emergency treatment</keyword>
</DOC>